Reclaim the Tumor Microenvironment via “Immunoforming”
Quadrant BioSciences Develops Saliva Tests to Detect Brain Diseases and Injuries
Top 10 Biopharma IPOs of January—June 2018
Number of Companies Going Public, and the Amount They Raise, Show Growth
Cannabinoid-Based Drugs Seek New High, Part I
Developers Anticipate Additional Approvals after FDA Nod for Epidiolex
Blood Protein Linked to Mental Disorders
Consciousness-Aiding Protein Produced by Cells Deep in the Brainstem
For full access to this article login to GEN Select now.
Next-Gen Sequencing Gets a Fix on Disease
- Recent years have seen rapid advances in the capacity of molecular biological techniques to simultaneously interrogate multiple targets on omics platforms. While these techniques are well established in basic research, they have more recently gained a foothold in clinical diagnostics, with an increasing number of laboratory tests incorporating ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.